Correlation of polymorphism of IL-8 and MMP-7 with occurrence and lymph node metastasis of early stage cervical cancer

Abstract

The IL-8 and MMP-7 genes participate in the carcinogenesis of many malignancies, but the role of both genes in cervical cancer is not fully elucidated. The aim of this study was to determine the frequency of IL-8 and MMP-7 gene mutations and to assess their effects on the risk of early stage cervical cancer and lymph node metastasis. The clinical stage and histological grade of cervical cancer were also studied. The peripheral blood from the patients with early stage cervical cancers and normal controls was collected and the DNA was extracted. The incidence of IL-8 and MMP-7 gene mutations was assessed by using tetra-primer amplification refractory mutation system polymerase chain reaction (ARMS PCR) and restriction fragment length polymorphism (RFLP). The data were statistically analyzed by x2 test. The results showed that: (1) The genotype frequency of IL-8 -251AT and TT was significantly higher in the cervical cancer group than in the normal control group (OR=2.290 and 2.619 respectively, P=0.001), and it was also higher in the lymphatic metastasis group than that without metastasis (OR=2.917, P=0.035); (2) The frequency of MMP-7 -181G/G genotype was significantly higher in the cervical cancer group and in the lymphatic metastasis group (P<0.05); (3) The incidence of IL-8 mutation was two times higher in IIa cervical cancer group than in Ib1 and Ib2 cervical cancer group (P=0.006). For the MMP-7 gene, there was statistically significant difference in the incidence of mutation between the Ib1, Ib2 and the IIa (P=0.000); (4) Different histological types and different grades of cervical cancer had different incidence of mutations, statistically. It was suggested that there was significant difference in the genotype of IL-8 -251TT and MMP-7 -181GG polymorphism between the cervical cancer group and the lymph node metastasis group. Moreover, individuals with IL-8 T allele or MMP-7 G allele carriers were at significantly higher risk of cervical cancer, particularly the early (IIa) and medium, poorly differentiated cervical cancer (G2+G3).

Keywords

interleukin-8 / matrix metalloproteinases / polymorphism / cervical cancer

References

[1] LandiS., MorenoV., Gioia-PatricolaL., et al.. Association of common polymorphisms in inflammatory genes interleukin (IL)-6, IL-8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res, 2003, 63(13): 3560-3566

[2] FreundA., ChauveauC., BrouilletJ.P., et al.. IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells. Oncogene, 2003, 22(2): 256-265

[3] LeeW.P., TaiD.I., LanK.H., et al.. The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res, 2005, 11(18): 6431-6441

[4] ShiraiK., OhmiyaN., TaguchiA., et al.. Interleukin-8 gene polymorphism associated with susceptibility to non-cardia gastric carcinoma with microsatellite instability. J Gastroenterol Hepatol, 2006, 21(7): 1129-1135

[5] BaridA., MormedeP., BohlenP.. Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor. Biochem Biophys Res Commun, 1985, 126(1): 358-364

[6] KochA.E., PolveriniP.J., KunkelS.L., et al.. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science, 1992, 258(5089): 1798-1801

[7] StrieterR.M., KunkelS.L., ElnerV.M., et al.. Interleukin-8. A corneal factor that induces neovascularization. Am J Pathol, 1992, 141(6): 1279-1284

[8] NickoloffB.J., MitraR.S., VaraniJ., et al.. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am J Pathol, 1994, 144(4): 820-828

[9] KochA.E., VolinM.V., WoodsJ.M., et al.. Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint. Arthritis Rheum, 2001, 44(1): 31-40

[10] XaubetA., AgustiC., LuburichP., et al.. Interleukin-8 expression in bronchoalveolar lavage cells in the evaluation of alveolitis in idiopathic pulmonary fibrosis. Respir Med, 1998, 92(2): 338-344

[11] ChokkiM., MitsuhashiH., KamimuraT.. Metalloprotease-dependent amphiregulin release mediates tumor necrosis factor-alpha-induced IL-8 secretion in the human airway epithelial cell line NCI-H292. Life Sci, 2006, 78(26): 3051-3057

[12] HeinzmannA., AhlertI., KurzT., et al.. Association study suggests opposite effects of polymorphisms within IL-8 on bronchial asthma and respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol, 2004, 114(3): 671-676

[13] HullJ., ThomsonA., KwiatkowskiD.. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax, 2000, 55(12): 1023-1027

[14] RossO.A., O’NeillC., ReaI.M., et al.. Functional promoter region polymorphism of the proinflammatory chemoki ne IL-8 gene associates with Parkinson’s disease in the Irish. Hum Immunol, 2004, 65(4): 340-346

[15] HamajimaN., KatsudaN., MatsuoK., et al.. High anti-Helicobacter pylori antibody seropositivity associated with the combination of IL-8 -251TT and IL-10 -819TT genotypes. Helicobacter, 2003, 8(2): 105-110

[16] van der KuylA.C., PolstraA.M., WeverlingG.J., et al.. An IL-8 gene promoter polymorphism is associated with the risk of the development of AIDS-related Kaposi’s sarcoma: a case-control study. AIDS, 2004, 18(8): 1206-1208

[17] QuantinB., MurphyG., BreathnachR.. Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members. Biochemistry, 1989, 28(13): 5327-5334

[18] NewellK.J., MatrisianL.M., DrimanD.K.. Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis. Mol Carcinog, 2002, 34(2): 59-63

[19] WittyJ.P., McDonnellS., NewelK.J., et al.. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res, 1994, 54(17): 4805-4812

[20] WilsonC.L., HeppnerK.J., LaboskyP.A., et al.. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci USA, 1997, 94(4): 1402-1407

[21] JormsjoS., WhatlingC., WalterD.H., et al.. Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol, 2001, 21(11): 1834-1839

[22] BarilleS., BatailleR., RappM.J., et al.. Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation. J Immunol, 1999, 163(10): 5723-5728

[23] EgebladM., WerbZ.. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer, 2002, 2(3): 161-174

[24] VairaktarisE., SerefoglouZ., YapijakisC., et al.. High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer. Anticancer Res, 2007, 27(4B): 2493-2498

[25] CanedoP., Castanheira-ValeA.J., LunetN., et al.. The interleukin-8-251*T/*A polymorphism is not associated with risk for gastric carcinoma development in a Portuguese population. Eur J Cancer Prev, 2008, 17(1): 28-32